HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michel F Otuki Selected Research

5,10- diphenyl- 15,20- di(1- methylpyridinium- 4- yl)porphyrin

1/2017Photodynamic effect of meso-(aryl)porphyrins and meso-(1-methyl-4-pyridinium)porphyrins on HaCaT keratinocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michel F Otuki Research Topics

Disease

4Inflammation (Inflammations)
07/2010 - 03/2007
2Pain (Aches)
08/2008 - 04/2005
1Wounds and Injuries (Trauma)
01/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2017
1Vitiligo
06/2012
1Melanoma (Melanoma, Malignant)
06/2012
1Hypersensitivity (Allergy)
11/2011
1Edema (Dropsy)
07/2010
1Infections
08/2008
1Visceral Pain
04/2005
1Hyperalgesia
04/2005
1Asthma (Bronchial Asthma)
02/2004
1Necrosis
02/2004
1Rheumatic Diseases (Rheumatism)
02/2004
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2004
1Atherosclerosis
02/2004

Drug/Important Bio-Agent (IBA)

2Complex MixturesIBA
07/2010 - 08/2009
2Peroxidase (Myeloperoxidase)IBA
08/2008 - 02/2004
2alpha-amyrinIBA
03/2007 - 04/2005
2HydrogenIBA
03/2007 - 04/2005
2TriterpenesIBA
03/2007 - 04/2005
1plexinIBA
01/2022
1PorphyrinsIBA
01/2017
15,10- diphenyl- 15,20- di(1- methylpyridinium- 4- yl)porphyrinIBA
01/2017
1Photosensitizing Agents (Photosensitizers)IBA
01/2017
1Melanins (Melanin)IBA
06/2012
1OxazoloneIBA
11/2011
1spinasterolIBA
07/2010
1kaurenoic acidIBA
07/2010
1Oleanolic AcidIBA
07/2010
1baurenolIBA
07/2010
1CarrageenanIBA
08/2008
1Phorbol EstersIBA
03/2007
1Morphine (MS Contin)FDA LinkGeneric
04/2005
1Glutamic Acid (Glutamate)FDA Link
04/2005
18-Bromo Cyclic Adenosine Monophosphate (8 Bromo Cyclic Adenosine Monophosphate)IBA
04/2005
1Pentacyclic TriterpenesIBA
04/2005
1beta-amyrinIBA
04/2005
1Matrix Metalloproteinases (MMPs)IBA
02/2004
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
02/2004
1Chemotactic FactorsIBA
02/2004
1InterferonsIBA
02/2004
1InterleukinsIBA
02/2004
1LipopolysaccharidesIBA
02/2004
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2004
1Phosphotransferases (Kinase)IBA
02/2004
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
02/2004
1ProstaglandinsIBA
02/2004
1Protein Kinases (Protein Kinase)IBA
02/2004
1Tetradecanoylphorbol AcetateIBA
02/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2004
1CytokinesIBA
02/2004
1Transforming Growth Factor beta (TGF-beta)IBA
02/2004
1Interleukin Receptors (Interleukin Receptor)IBA
02/2004
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
02/2004
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
02/2004
1Monocyte Chemoattractant ProteinsIBA
02/2004
1Chemokine CCL5IBA
02/2004
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
02/2004
1E-SelectinIBA
02/2004
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
02/2004
1Chemokine ReceptorsIBA
02/2004
1Mitogen-Activated Protein KinasesIBA
02/2004
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2004
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2004
1Janus KinasesIBA
02/2004

Therapy/Procedure

2Traditional Medicine (Folk Remedies)
06/2012 - 08/2008
1Analgesia
04/2005